return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Media Centre
Home
>
Investor Videos
Overview
Newsletters
Coverage
Investor Videos
NOX Insights
Noxopharm Podcasts
Investor Videos
Noxopharm CEO Discusses Subsidiary, Pharmorage with Proactive Investors
December 22, 2021
Noxopharm 2021 AGM
November 17, 2021
Noxopharm Talks to Proactive Investors about NOXCOVID trial Phase 1 results
Aug 24, 2021
Noxopharm Presents at Broker Briefing 1 July 2021
Jul 5, 2021
V-Con: Biotech - Noxopharm (ASX:NOX)
Jul 1, 2021
Noxopharm's Dr Graham Kelly outlines its four pillars oncology strategy (proactiveinvestors.com.au)
May 20, 2021
Noxopharm Presents to Share Café Hidden Gems Webinar
May 17, 2021
How Noxopharm is harnessing the power of the immune system with Veyonda®
Sep 10, 2020
Interview with Proactive: Noxopharm CEO encouraged by positive interim data from NOXCOVID trial
Apr 23, 2021
The Inside Network Interview with NOX CEO
Apr 27, 2021
Noxopharm DARRT Treatment Animation
Nov 17, 2020
Veyonda
®
Mode of Action Animation
Nov 17, 2020
See more videos
